Segall Bryant & Hamill’s Array Biopharma Inc ARRY Stock Holding History

Segall Bryant & Hamill’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-33,156	Closed	-$1.54M	–	868
2019 Q2	$1.54M	Buy	33,156 +137	+0.4%	+$3.85K	0.02%	449
2019 Q1	$805K	Sell	33,019 -13,485	-29%	-$281K	0.01%	581
2018 Q4	$663K	Buy	46,504 +9,852	+27%	+$149K	0.01%	596
2018 Q3	$557K	Sell	36,652 -127	-0.3%	-$1.95K	0.01%	655
2018 Q2	$617K	Buy	+36,779	New	+$585K	0.01%	628

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Segall Bryant & Hamill's ARRY Position: Q3 2019 in Review

Segall Bryant & Hamill sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 33,156 shares — an estimated $1.54M sold.

Segall Bryant & Hamill first reported a position in ARRY in Q2 2018 and held it in 5 quarters. The position peaked at $1.54M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Segall Bryant & Hamill reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Segall Bryant & Hamill sold 33,156 Array Biopharma Inc shares in Q3 2019, an estimated $1.54M.
Segall Bryant & Hamill first reported a position in Array Biopharma Inc in Q2 2018 and held it in 5 quarters.
Segall Bryant & Hamill's Array Biopharma Inc position peaked at $1.54M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Segall Bryant & Hamill's 13F filing for Q3 2019, filed 12 Nov 2019.